Comments
Loading...

Allogene Therapeutics (ALLO) Stock Price, Quote, News & History

ALLONASDAQ
Logo brought to you by Benzinga Data
$1.50
-0.01-0.66%
Last update: Dec 15, 9:09 AM
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
-
Close
-
Volume / Avg.
16.27K / 2.74M
Day Range
- - -
52 Wk Range
0.86 - 3.78
Market Cap
$337.10M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
10%
Days to Cover
7.62

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
2
Aug
1
Oct
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
-
Close
-
Volume / Avg.
16.27K / 2.74M
Day Range
- - -
52 Wk Range
0.86 - 3.78
Market Cap
$337.10M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
10%
Days to Cover
7.62

About

Sector
Health Care
Industry
Biotechnology
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALLO
TECX

FAQ

Q

How do I buy Allogene Therapeutics (ALLO) stock?

A

You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Allogene Therapeutics (ALLO) competitors?

Q

What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?

A

Allogene Therapeutics has a consensus price target of $10.54.

Q

What is the current price for Allogene Therapeutics (ALLO)?

A

The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.5 last updated December 15, 2025 at 9:09 AM EST.

Q

Does Allogene Therapeutics (ALLO) pay a dividend?

A

There are no upcoming dividends for Allogene Therapeutics.

Q

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

A

Allogene Therapeutics does not have any upcoming earnings scheduled.

Q

Is Allogene Therapeutics (ALLO) going to split?

A

There is no upcoming split for Allogene Therapeutics.

Q

What sector and industry does Allogene Therapeutics (ALLO) operate in?

A

Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.